Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors

被引：19
|
作者：
Kolesar, Jill [1 ,2 ]
Huang, Wei [1 ,3 ]
Eickhoff, Jens [1 ,4 ]
Hahn, Kristine [1 ,5 ]
Alberti, Dona [1 ,5 ]
Attia, Steven [1 ,5 ]
Schelman, William [1 ,5 ]
Holen, Kyle [1 ,5 ]
Traynor, Anne [1 ,5 ]
Ivy, Percy [6 ]
Wilding, George [1 ,5 ]
机构：
[1] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI 53792 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol, Madison, WI 53792 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat, Madison, WI 53792 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA
[6] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 2009年 / 64卷 / 01期
关键词：
Triapine (R); 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone; Ribonucleotide reductase; Automated quantitative immunohistochemistry (AQUA); Quantitative real time PCR; PHASE-II; CELL-PROLIFERATION; R2; COMPONENT; IN-VITRO; CANCER; OVEREXPRESSION; GEMCITABINE; TRANSFORMATION; RESISTANCE; INCREASES;
D O I：
10.1007/s00280-008-0845-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The purpose of this study was to evaluate baseline RRM2 protein and gene expression in tumors of patients receiving 3-AP. Tumor blocks from patients enrolled in phase I and II clinical studies using 3-AP, were evaluated for RRM2 gene and protein expression by quantitative real time polymerase chain reaction (Q-RTPCR) and automated quantitative analysis (AQUA). Esophageal and gastric cancers overexpressed RRM2 protein when compared to prostate cancer (Z-score, 0.68 +/- A 0.94 SD, vs 0.41 +/- A 0.84 SD, respectively; p = 0.04). Esophageal and gastric cancers also overexpressed RRM2 mRNA when compared to prostate cancer (relative gene expression 2.56 +/- A 1.49 SD, vs 0.29 +/- A 0.20 SD, respectively; p = 0.02). Protein and gene expression were moderately associated (Spearman's rank correlation = 0.30; p = 0.12). RRM2 gene and protein expression varies by tumor type.
引用
收藏
页码：79 / 86
页数：8
相关论文
共 50 条
  • [31] CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer
    Fang, Zejun
    Lin, Aifen
    Chen, Jiaoe
    Zhang, Xiaomin
    Liu, Hong
    Li, Hongzhang
    Hu, Yanyan
    Zhang, Xia
    Zhang, Jiangang
    Qiu, Lanlan
    Mei, Lingming
    Shao, Jimin
    Chen, Xiang
    ONCOTARGET, 2016, 7 (47) : 78055 - 78068
  • [32] Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
    Souglakos, J.
    Boukovinas, I.
    Taron, M.
    Mendez, P.
    Mavroudis, D.
    Tripaki, M.
    Hatzidaki, D.
    Koutsopoulos, A.
    Stathopoulos, E.
    Georgoulias, V.
    Rosell, R.
    BRITISH JOURNAL OF CANCER, 2008, 98 (10) : 1710 - 1715
  • [33] Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
    Hang Zhang
    Xiyong Liu
    Charles D Warden
    Yasheng Huang
    Sofia Loera
    Lijun Xue
    Suzhan Zhang
    Peiguo Chu
    Shu Zheng
    Yun Yen
    BMC Cancer, 14
  • [34] Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
    J Souglakos
    I Boukovinas
    M Taron
    P Mendez
    D Mavroudis
    M Tripaki
    D Hatzidaki
    A Koutsopoulos
    E Stathopoulos
    V Georgoulias
    R Rosell
    British Journal of Cancer, 2008, 98 : 1710 - 1715
  • [35] HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma
    Jones, Richard J.
    Baladandayuthapani, Veerabhadran
    Neelapu, Sattva
    Fayad, Luis E.
    Romaguera, Jorge E.
    Wang, Michael
    Sharma, Rakesh
    Yang, Dajun
    Orlowski, Robert Z.
    BLOOD, 2011, 118 (15) : 4140 - 4149
  • [36] The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients
    Su, Ying-Fang
    Wu, Tzu-Fan
    Ko, Jiunn-Liang
    Tsai, Hsiu-Ting
    Tee, Yi-Torng
    Chien, Ming-Hsien
    Chou, Chi-Hung
    Lin, Wea-Lung
    Low, Hui-Ying
    Chou, Ming-Yung
    Yang, Shun-Fa
    Wang, Po-Hui
    PLOS ONE, 2014, 9 (03):
  • [37] RETRACTED: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine (Retracted article. See FEB, 2023)
    Duxbury, MS
    Ito, H
    Zinner, MJ
    Ashley, SW
    Whang, EE
    ONCOGENE, 2004, 23 (08) : 1539 - 1548
  • [38] The Conserved Lys-95 Charged Residue Cluster Is Critical for the Homodimerization and Enzyme Activity of Human Ribonucleotide Reductase Small Subunit M2
    Chen, Xinhuan
    Xu, Zhijian
    Zhang, Lingna
    Liu, Hongchuan
    Liu, Xia
    Lou, Meng
    Zhu, Lijun
    Huang, Bingding
    Yang, Cai-Guang
    Zhu, Weiliang
    Shao, Jimin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (02) : 909 - 920
  • [39] Pterostilbene inhibits hepatocellular carcinoma proliferation and HBV replication by targeting ribonucleotide reductase M2 protein
    Wang, Rui
    Xu, Zhijian
    Tian, Jiaping
    Liu, Qian
    Dong, Jingwen
    Guo, Lijuan
    Hai, Boning
    Liu, Xia
    Yao, Hangping
    Chen, Zhi
    Xu, Junjie
    Zhu, Lijun
    Chen, Haiyi
    Hou, Tingjun
    Zhu, Weiliang
    Shao, Jimin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2975 - +
  • [40] Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status
    Mah, Vei
    Alavi, Mohammad
    Marquez-Garban, Diana C.
    Maresh, Erin L.
    Kim, Sara R.
    Horvath, Steve
    Bagryanova, Lora
    Huerta-Yepez, Sara
    Chia, David
    Pietras, Richard
    Goodglick, Lee
    PLOS ONE, 2015, 10 (05):
12345